MYEF2
Basic information
Region (hg38): 15:48134632-48178353
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (10 variants)
- Oculocutaneous albinism type 6 (3 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYEF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 12 | 69 | 39 | 127 | ||
Total | 12 | 5 | 95 | 40 | 2 |
Highest pathogenic variant AF is 0.0000461
Variants in MYEF2
This is a list of pathogenic ClinVar variants found in the MYEF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-48134876-T-C | Uncertain significance (Jan 16, 2022) | |||
15-48134886-CT-C | Pathogenic (Nov 07, 2018) | |||
15-48134888-C-G | Oculocutaneous albinism type 6 | Pathogenic (Mar 01, 2023) | ||
15-48134891-C-T | Uncertain significance (Oct 17, 2022) | |||
15-48134892-A-C | Likely benign (Jan 15, 2024) | |||
15-48134896-T-A | Uncertain significance (Oct 07, 2021) | |||
15-48134897-C-G | Skin/hair/eye pigmentation, variation in, 4 | Pathogenic (Mar 26, 2019) | ||
15-48134897-C-T | Uncertain significance (Oct 24, 2022) | |||
15-48134899-T-C | Uncertain significance (Feb 11, 2022) | |||
15-48134907-C-T | Likely benign (Jul 29, 2022) | |||
15-48134912-TCAGAGACTGTG-T | Pathogenic (Feb 02, 2022) | |||
15-48134915-G-A | Oculocutaneous albinism type 6 | Pathogenic (Sep 21, 2022) | ||
15-48134922-T-A | Oculocutaneous albinism type 6 | Pathogenic (Jan 17, 2017) | ||
15-48134927-C-T | Uncertain significance (Nov 01, 2022) | |||
15-48134928-G-A | SLC24A5-related disorder | Conflicting classifications of pathogenicity (Jul 03, 2023) | ||
15-48134928-G-C | Likely benign (Sep 01, 2022) | |||
15-48134931-C-T | Likely benign (Nov 15, 2022) | |||
15-48134938-A-G | Uncertain significance (Jun 28, 2022) | |||
15-48134940-T-A | Conflicting classifications of pathogenicity (Jan 01, 2024) | |||
15-48134952-T-C | Likely benign (Nov 20, 2023) | |||
15-48134954-T-C | Uncertain significance (Mar 18, 2022) | |||
15-48134956-G-C | Inborn genetic diseases | Uncertain significance (Oct 20, 2023) | ||
15-48134957-GTATAA-G | Pathogenic (Jun 05, 2022) | |||
15-48134963-T-TATTA | Skin/hair/eye pigmentation, variation in, 4 | association (Dec 15, 2012) | ||
15-48134977-G-A | Uncertain significance (Nov 28, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYEF2 | protein_coding | protein_coding | ENST00000324324 | 17 | 39090 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.635 | 0.365 | 125086 | 4 | 655 | 125745 | 0.00262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.53 | 258 | 337 | 0.766 | 0.0000173 | 3962 |
Missense in Polyphen | 75 | 125.2 | 0.59903 | 1480 | ||
Synonymous | 2.97 | 66 | 105 | 0.631 | 0.00000539 | 1091 |
Loss of Function | 4.28 | 7 | 33.9 | 0.207 | 0.00000185 | 414 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00292 | 0.00292 |
Ashkenazi Jewish | 0.00229 | 0.00228 |
East Asian | 0.0000598 | 0.0000544 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.00439 | 0.00435 |
Middle Eastern | 0.0000598 | 0.0000544 |
South Asian | 0.000954 | 0.000948 |
Other | 0.00395 | 0.00375 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor of the myelin basic protein gene (MBP). Binds to the proximal MB1 element 5'-TTGTCC-3' of the MBP promoter. Its binding to MB1 and function are inhibited by PURA (By similarity). {ECO:0000250}.;
- Pathway
- Physiological and Pathological Hypertrophy of the Heart;MicroRNAs in cardiomyocyte hypertrophy;TFs Regulate miRNAs related to cardiac hypertrophy;Mitochondrial Gene Expression
(Consensus)
Recessive Scores
- pRec
- 0.308
Intolerance Scores
- loftool
- 0.531
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.54
Haploinsufficiency Scores
- pHI
- 0.385
- hipred
- Y
- hipred_score
- 0.735
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.826
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myef2
- Phenotype
Zebrafish Information Network
- Gene name
- myef2
- Affected structure
- hematopoietic stem cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;myotube differentiation;neuron differentiation;regulation of mRNA stability involved in response to oxidative stress
- Cellular component
- nucleus;cytoplasm;post-mRNA release spliceosomal complex;ribonucleoprotein complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;single-stranded DNA binding;RNA binding;mRNA binding